HSD3B1 mediated anti-androgen resistance in prostate cancer requires specific androgen precursors

被引：0
|
作者：
Armstrong, Cameron M. [1 ]
Liu, Chengfei [1 ]
Lou, Wei [1 ]
Lombard, Alan P. [1 ]
Evans, Christopher [1 ]
Gao, Allen C. [1 ]
机构：
[1] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3030
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
    Hearn, Jason W. D.
    AbuAli, Ghada
    Magi-Galluzzi, Cristina
    Reddy, Chandana A.
    Chang, Kai-Hsiung
    Klein, Eric A.
    Sharifi, Nima
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
    Hearn, Jason W. D.
    AbuAli, Ghada
    Magi-Galluzzi, Cristina
    Reddy, Chandana A.
    Chang, Kai-Hsiung
    Klein, Eric A.
    Sharifi, Nima
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [3] HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
    Hearn, Jason W. D.
    AbuAli, Ghada
    Reichard, Chad A.
    Reddy, Chandana A.
    Magi-Galluzzi, Cristina
    Chang, Kai-Hsiung
    Carlson, Rachel
    Rangel, Laureano J.
    Reagan, Kevin
    Davis, Brian
    Karnes, Jeffrey
    Kohli, Manish
    Tindall, Donald J.
    Klein, Eric A.
    Sharifi, Nima
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer
    Daniel Hettel
    Nima Sharifi
    Nature Reviews Urology, 2018, 15 : 191 - 196
  • [5] HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer
    Hettel, Daniel
    Sharifi, Nima
    NATURE REVIEWS UROLOGY, 2018, 15 (03) : 191 - 196
  • [6] HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
    Hearn, Jason W. D.
    AbuAli, Ghada
    Reichard, Chad A.
    Reddy, Chandana A.
    Magi-Galluzzi, Cristina
    Chang, Kai-Hsiung
    Carlson, Rachel
    Rangel, Laureano
    Reagan, Kevin
    Davis, Brian J.
    Karnes, R. Jeff Rey
    Kohli, Manish
    Tindall, Donald
    Klein, Eric A.
    Sharifi, Nima
    LANCET ONCOLOGY, 2016, 17 (10): : 1435 - 1444
  • [7] HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer
    Fei-fei Han
    Lu-lu Ren
    Ling-ling Xuan
    Ya-li LV
    He Liu
    Li-li Gong
    Zhuo-ling An
    Li-hong Liu
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 103 - 112
  • [8] HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer
    Han, Fei-Fei
    Ren, Lu-Lu
    Xuan, Ling-Ling
    Lv, Ya-Li
    Liu, He
    Gong, Li-Li
    An, Zhuo-Ling
    Liu, Li-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (01) : 103 - 112
  • [9] Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Zhang, Haozhe
    Zhou, Yi
    Xing, Zengzhen
    Sah, Rajiv Kumar
    Hu, Junqi
    Hu, Hailiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [10] Re: HSD3B1 and Resistance to Androgen-Deprivation Therapy in Prostate Cancer: A Retrospective, Multicohort Study
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2017, 197 (01): : 150 - 150
12345